Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 29, 2022

SELL
$74.15 - $99.36 $807,938 - $1.08 Million
-10,896 Closed
0 $0
Q4 2021

Feb 02, 2022

SELL
$86.01 - $102.89 $20,900 - $25,002
-243 Reduced 2.18%
10,896 $1.12 Million
Q3 2021

Oct 28, 2021

SELL
$84.7 - $96.31 $244,274 - $277,758
-2,884 Reduced 20.57%
11,139 $974,000
Q2 2021

Jul 29, 2021

BUY
$76.44 - $89.57 $58,858 - $68,968
770 Added 5.81%
14,023 $1.26 Million
Q1 2021

Apr 29, 2021

SELL
$67.36 - $80.76 $39,742 - $47,648
-590 Reduced 4.26%
13,253 $1.01 Million
Q4 2020

Jan 29, 2021

BUY
$53.08 - $69.86 $137,742 - $181,286
2,595 Added 23.07%
13,843 $943,000
Q3 2020

Oct 28, 2020

BUY
$51.29 - $65.09 $101,554 - $128,878
1,980 Added 21.36%
11,248 $598,000
Q2 2020

Jul 28, 2020

BUY
$34.32 - $62.43 $318,077 - $578,601
9,268 New
9,268 $540,000

Others Institutions Holding SYNH

About Syneos Health, Inc.


  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track This Portfolio

Track Emerald Advisers, LLC Portfolio

Follow Emerald Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Advisers, LLC with notifications on news.